KT Medical Service PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	709.22	703.84	596.8	456.11	377.63	309.37
Other Revenue	3.47	3.42	3.87	4.42	6.52	3.43
Revenue	712.68	707.27	600.67	460.52	384.14	312.8
Revenue Growth (YoY)	10.68%	17.75%	30.43%	19.88%	22.81%	46.47%
Cost of Revenue	576.75	571.29	500.75	373.46	305.79	247.15
Gross Profit	135.93	135.98	99.92	87.07	78.35	65.66
Selling, General & Admin	80.18	75.85	73.77	66.75	54.66	39.92
Operating Expenses	79.35	75.09	73.38	66.85	49.71	40.14
Operating Income	56.58	60.89	26.54	20.22	28.65	25.51
Interest Expense	-6.33	-5.81	-3.45	-2.83	-3.53	-5.68
Interest & Investment Income	1.07	1.12	1.23	1.06	0.94	0.99
Pretax Income	51.32	56.2	24.32	18.45	26.06	20.82
Income Tax Expense	11.22	12.11	5.86	4.86	4.96	4.02
Earnings From Continuing Operations	40.1	44.09	18.46	13.59	21.1	16.8
Minority Interest in Earnings	0.18	0.27	0.7	0.62	0.08	-
Net Income	40.28	44.36	19.16	14.21	21.18	16.8
Net Income to Common	40.28	44.36	19.16	14.21	21.18	16.8
Net Income Growth	40.52%	131.50%	34.85%	-32.92%	26.05%	-
Shares Outstanding (Basic)	300	300	300	300	227	181
Shares Outstanding (Diluted)	300	300	300	300	227	181
Shares Change (YoY)	-0.16%	-	-	32.28%	25.21%	75.16%
EPS (Basic)	0.13	0.15	0.06	0.05	0.09	0.09
EPS (Diluted)	0.13	0.15	0.06	0.05	0.09	0.09
EPS Growth	40.75%	131.50%	34.85%	-49.29%	0.67%	-
Free Cash Flow	-18.65	-24.29	-3.78	-143.5	-45.06	-40.07
Free Cash Flow Per Share	-0.06	-0.08	-0.01	-0.48	-0.20	-0.22
Dividend Per Share	0.013	0.013	0.023	0.014	0.033	-
Dividend Growth	-44.21%	-44.21%	66.43%	-57.19%	-	-
Gross Margin	19.07%	19.23%	16.63%	18.91%	20.40%	20.99%
Operating Margin	7.94%	8.61%	4.42%	4.39%	7.46%	8.16%
Profit Margin	5.65%	6.27%	3.19%	3.08%	5.51%	5.37%
Free Cash Flow Margin	-2.62%	-3.43%	-0.63%	-31.16%	-11.73%	-12.81%
EBITDA	99.42	102.46	62.11	43.98	46.2	41.13
EBITDA Margin	13.95%	14.49%	10.34%	9.55%	12.03%	13.15%
D&A For EBITDA	42.83	41.57	35.57	23.76	17.55	15.62
EBIT	56.58	60.89	26.54	20.22	28.65	25.51
EBIT Margin	7.94%	8.61%	4.42%	4.39%	7.46%	8.16%
Effective Tax Rate	21.86%	21.55%	24.11%	26.33%	19.02%	19.29%
Revenue as Reported	713.75	708.39	601.9	461.58	385.08	313.79

Source: S&P Global Market Intelligence. Standard template. Financial Sources.